Sailong Pharmaceutical Group Co (SZSE:002898) Days Sales Outstanding : 127.75 (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Sailong Pharmaceutical Group Co Days Sales Outstanding?

Sailong Pharmaceutical Group Co's average Accounts Receivable for the three months ended in Mar. 2025 was ¥75.7 Mil. Sailong Pharmaceutical Group Co's Revenue for the three months ended in Mar. 2025 was ¥54.1 Mil. Hence, Sailong Pharmaceutical Group Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 127.75.

The historical rank and industry rank for Sailong Pharmaceutical Group Co's Days Sales Outstanding or its related term are showing as below:

SZSE:002898' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.13 Med: 59.31 Max: 236.95
Current: 107.85

During the past 12 years, Sailong Pharmaceutical Group Co's highest Days Sales Outstanding was 236.95. The lowest was 0.13. And the median was 59.31.

SZSE:002898's Days Sales Outstanding is ranked worse than
72.43% of 845 companies
in the Biotechnology industry
Industry Median: 69.43 vs SZSE:002898: 107.85

Sailong Pharmaceutical Group Co's Days Sales Outstanding increased from Mar. 2024 (50.18) to Mar. 2025 (127.75).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Sailong Pharmaceutical Group Co Days Sales Outstanding Historical Data

The historical data trend for Sailong Pharmaceutical Group Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sailong Pharmaceutical Group Co Days Sales Outstanding Chart

Sailong Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

236.95

77.39

82.75

52.53

66.08

Sailong Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															50.18	70.45	121.68	151.22	127.75

Competitive Comparison of Sailong Pharmaceutical Group Co's Days Sales Outstanding

For the Biotechnology subindustry, Sailong Pharmaceutical Group Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sailong Pharmaceutical Group Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sailong Pharmaceutical Group Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Sailong Pharmaceutical Group Co's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Sailong Pharmaceutical Group Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Sailong Pharmaceutical Group Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (28.39	+	67.047)	/	2 )	/	263.567	*	365
=	47.7185					/	263.567	*	365
=	66.08

Sailong Pharmaceutical Group Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (67.047	+	84.401)	/	2 )	/	54.087	*	365 / 4
=	75.724					/	54.087	*	365 / 4
=	127.75

Sailong Pharmaceutical Group Co (SZSE:002898) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Sailong Pharmaceutical Group Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Sailong Pharmaceutical Group Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Sailong Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sailong Pharmaceutical Group Co Ltd (SZSE:002898) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 47, Haibin South Road, 2nd Floor, Everbright International Trade Center, Guangdong Province, Zhuhai, CHN, 519015

Website

http://www.sailong.cn

Sailong Pharmaceutical Group Co Ltd is a pharmaceutical company. It is mainly engaged in the development, production, marketing and technical services of pharmaceuticals. The company's products are mainly concentrated in the fields of the nervous system, cardiovascular and digestive system. The product range includes monosialin tetrahexose ganglioside sodium injections, brain protein hydrolyzate for injections, clindamycin phosphate for injections, pantoprazole sodium for injections and milrinon injections, among others.

Executives

Tang Lin	Director
Long Zhi Xiang	Director
Deng Yong Jun	Supervisors
Zhou Bei	Supervisors
Li Jian Feng	Directors, executives

Sailong Pharmaceutical Group Co Headlines

No Headlines